ArticleAbdominal radiology (New York)2026
CT radiomics and topology-based intratumoral heterogeneity for preoperative prediction of nuclear β-catenin expression in hepatocellular carcinoma.
Article in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundNuclear β-catenin accumulation reflects activation of the Wnt/β-catenin pathway in hepatocellular carcinoma (HCC), but noninvasive preoperative prediction of this immunohistochemical phenotype remains incompletely established. PURPOSE: To develop and externally validate CT radiomics and topology-based intratumoral heterogeneity (ITH) models for preoperative prediction of nuclear β-catenin expression in HCC. MATERIALS AND
methodsThis multicenter retrospective study included 1029 patients with histopathologically confirmed HCC. Patients from two participating institutions formed the development cohort and were split into training (n=620; nuclear β-catenin-positive, 293) and internal validation (n=267; nuclear β-catenin-positive, 126) sets. Patients from an independent third institution formed the external validation cohort (n=142; nuclear β-catenin-positive, 43). Whole-tumor portal venous phase CT radiomics features and topology-based ITH features were extracted from the audited image-mask cohort. Model discrimination, calibration, and clinical utility were evaluated using AUC, bootstrap 95% confidence intervals, calibration summaries, Brier scores, and decision curve analysis.
resultsIn external validation, AUCs were 0.677 for the clinical model, 0.862 for the radiomics model, 0.857 for the ITH model, 0.831 for the core ITH model, 0.863 for the radiomics-ITH model, and 0.886 for the stacking model. Compared with radiomics alone, stacking showed a numerical ΔAUC of 0.024 (95% CI, -0.010 to 0.060; P=0.180).
conclusionCT radiomics and topology-based ITH features showed external predictive value for nuclear β-catenin expression in HCC. The stacking model had the highest external AUC, but its improvement over radiomics alone was not statistically significant. If prospectively validated, these CT-based approaches could complement tissue assessment for pretreatment biological stratification.
Indexed as
Identifiers
42859213What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.